Patents Assigned to InSite Vision, Incorporated
  • Methods of ophthalmic administration
    Patent number: 6378526
    Abstract: Intrascleral injection of a therapeutic or diagnostic material at a location overlying the retina provides a minimally invasive technique for delivering the agent to the posterior segment of the eye. The procedure also allows for close proximity of the material to the targeted site and can be effectively used to treat conditions associated with the posterior segment of the eye, including macular degeneration, vein occlusion, and diabetic retinopathy.
    Type: Grant
    Filed: August 3, 1998
    Date of Patent: April 30, 2002
    Assignee: InSite Vision, Incorporated
    Inventors: Lyle M. Bowman, James F. Pfeiffer, Leslie A. Clark, Karl L. Hecker
  • Topical treatment or prevention of ocular infections
    Patent number: 6239113
    Abstract: The topical application of an azalide antibiotic such as azithromycin to the eye is useful in treating or preventing ocular infections. In one embodiment, the azalide antibiotic is supplied to the eye in a depot for sustained release. A more convenient dosing regimen can also be provided by the use of an appropriate depot. Furthermore, a composition containing a combination of medicaments is also provided.
    Type: Grant
    Filed: July 2, 1999
    Date of Patent: May 29, 2001
    Assignee: InSite Vision, Incorporated
    Inventors: Chandler R. Dawson, Lyle M. Bowman